Sekkei Bio, an India-based firm devoted to drug and vaccine design, has carried out CDD Vault as the principle platform to home its research data.
BENGALORE, INDIA, September 15, 2022 /EINPresswire.com/ — Collaborative Drug Discovery (CDD) introduced right this moment that Sekkei Bio, an India-based firm devoted to constructing cutting-edge applied sciences for drug and vaccine design with world impression, has carried out CDD Vault as the principle platform to home its research data. Sekkei has made massive progress towards discovering therapies for diabetes and ache.
Sekkei Bio has a administration group with an extended monitor file of efficiently bringing medicine to market. The firm has constructed an in-silico discovery engine primarily based on this expertise, which permits them to design and develop novel medicine and excipients. The in-silico engine drives their in-house packages and may also be accessed by different organizations by way of a variety of versatile collaboration choices. Sekkei Bio has additionally created an mRNA platform that gives an economical and scalable answer for vaccines and therapeutics tailored to the regional want.
Key to the progress of the Sekkei drug discovery program is the implementation of CDD Vault to retailer, handle and analyze their research data – together with peptides, small molecules, and assay data – used to mannequin the brand new medicine. The implementation of CDD Vault is vital to the corporate’s collaborations because it permits data safety proper from question dealing with to library handover and permits for interactions with companions and collaborators in actual time.
“Several of us at Sekkei have worked with CDD in previous tenures. We knew of the power of the platform and how it will help organize data and make them traceable, searchable and reusable,” stated Dr. Monalisa Chatterji, Director and co-founder at Sekkei Bio. “Clean and organized data are the cornerstone of IP-able scientific progress. It is important to us to keep the traceability of the data and ensure that our data is secure yet readily accessible at the same time,” acknowledged Dr. Anirudh Ranganathan, co-founder of Sekkei Bio.
“We have known the Sekkei team for a long time, and they have an impressive track record delivering new drugs. We are proud that CDD Vault will be supporting their research again in this new venture,” stated Dr Barry Bunin, CEO of CDD.
ABOUT COLLABORATIVE DRUG DISCOVERY, INC.
CDD’s (www.collaborativedrug.com) flagship product, “CDD Vault®”, is used to handle chemical registration, structure-activity relationships (SAR), and securely scale collaborations. CDD Vault® is a hosted database answer for safe administration and sharing of organic and chemical data. It permits you to intuitively set up chemical buildings and organic examine data, and collaborate with inner or exterior companions by way of a simple to use internet interface. Available modules inside CDD Vault embrace Activity & Registration, Visualization, Inventory, and ELN.
Abraham Wang
Collaborative Drug Discovery
e mail us right here
Visit us on social media:
Facebook
Twitter
LinkedIn
